In this video, neurodevelopmental pediatrician Frank Lopez, MD, of Pediatric Neurology PA, Winter Park, Florida, addresses the myth that anxiety and mood disorders do not co-occur with attention-deficit/hyperactivity disorder (ADHD).

People with ADHD may be facing disruptive changes in their lives due to the COVID-19 pandemic. These changes may trigger new or worsening symptoms of ADHD or other mental health conditions, such as anxiety or depression. Creating a routine, reframing your symptoms, setting a sleep routine, and socializing digitally may help relieve these symptoms.

Irritability appears to be a potent independent predictor of increased risk for suicidality in children and adolescents with ADHD, Tomer Levy, MD, said at the virtual congress of the European College of Neuropsychopharmacology.

Recently, in an article posted in the New England Journal of Medicine, Samuele Cortese, MD, PhD, Professor of Child and Adolescent Psychiatry, University of Southampton, examined the safety and efficacy of medications currently being used to treat ADHD. Cortese said in an interview with HCPLive® the review might be a step toward precision medicine because…

In this video, Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses emerging treatments and mechanisms of action for attention deficit/hyperactivity disorder (ADHD). Dr. Maletic is Clinical Professor of Psychiatry, University of South Carolina School of Medicine, Greenville, and spoke at the Psych Congress 2020 psychopharmacology preconference on “ADHD Across the Lifespan: How Neurobiology Informs…

Low levels of key, body-regulating chemicals in mothers during the first three months of pregnancy may interfere with the baby’s brain development, a large study shows.

The findings from Duke Health researchers, appearing online Oct. 19 in the journal Scientific Reports, provide evidence that health care utilization patterns in a baby’s first year can be gleaned from electronic medical records, serving as a roadmap to provide timely diagnoses and treatments that could improve outcomes and reduce health care costs.

A report published by The Journal of the American Medical Association in September found that symptoms of depression have become three times more prevalent in the United States since the COVID-19 pandemic began…This staggering statistic is of even greater concern for the 17 million children and adults in the US with attention-deficit/hyperactivity disorder (ADHD), who…

With the ongoing coronavirus disease 2019 (COVID-19) pandemic raging on, there is a need for in-home therapy tools for children with attention-deficit hyperactivity disorder (ADHD). One area where that can be achieved is through virtual reality platforms. While VR likely won’t be able to replace the cancelled sports and social events, it does offer an…

In this video, neuropsychiatrist Theresa Cerulli, MD, addresses the myth that most cases of attention-deficit/hyperactivity disorder (ADHD) are simple to treat. ADHD is in fact a complex and heterogenous disorder that is difficult to both diagnose and treat, she says.

Following the diagnosis of attention-deficit/hyperactivity disorder (ADHD), the next step is treatment, which can include parent behavior management training, school-based interventions, and medication. Here’s a look at the latest in ADHD treatments.

Attention-deficit/hyperactivity disorder (ADHD) was first recognized over 100 years ago, but the diagnostic criteria has changed over the years. Here’s a look at the latest guidance for diagnosing ADHD.